THE APEX TIMES
The reported withdrawal comes one day before a scheduled vote in the Senate health committee on the Trump nominee.
The White House has withdrawn its nomination of Heidi Overton to lead the Food and Drug Administration, multiple news outlets reported on November 17-18, with the move coming on the eve of a key Senate committee vote. A White House official told The Guardian that the nomination would be dropped.
The outlets reported that President Donald Trump nominated Overton in August to serve as FDA commissioner. The nomination was set for consideration by senators on the Health, Education, Labor and Pensions committee, according to the reporting.
Overton is a physician and has been described by outlets as a prominent abortion opponent. According to the coverage, Overton has spent much of her professional career working directly for Trump, and her nomination faced scrutiny in Congress ahead of the committee vote.
A committee vote would have determined whether the nomination advanced to the full Senate for confirmation proceedings. With the nomination withdrawn, the next step in the appointment process would depend on whether the administration submits a new nominee or leaves the seat open while it selects a replacement.
The reports arrived amid broader debate over FDA leadership and the agency’s regulatory role in areas such as clinical oversight, labeling rules, and access to medications, issues that frequently draw political attention. While the FDA commissioner position requires Senate confirmation, the reported withdrawal changes the timing and procedural posture of the nomination without a floor vote.
As of this writing, Apex Times has not found a primary White House, Federal Register, or Senate document confirming the withdrawal. The development is therefore reported based on outlet accounts, and any official record of the nomination’s status will determine the precise administrative timeline and next nomination steps.
Comments
Community guidelines. Comments may be removed for violations.
Loading comments...